CIDARA THERAPEUTICS, INC.
CIDARA THERAPEUTICS, INC. is a registered legal entity registered in United States under 604624397, and its current status with Washington Secretary of State is active. The company was incorporated on 6 July 2020 and lists its registered address as SAN DIEGO, United States. 5 shareholders are on record for CIDARA THERAPEUTICS, INC., and since every one of them is a company rather than an individual, this particular filing does not on its own establish an ultimate beneficial owner (UBO) — identifying one would mean tracing the ownership of each shareholding company in turn. This profile is sourced directly from Washington Secretary of State and was last updated on 6 October 2026.
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Five shareholders are currently on record for CIDARA THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing.
The largest of these is Bain Capital Life Sciences Investors, LLC, holding 16.1% — the largest recorded stake — followed by VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund at 4.1%; the remaining 3 shareholders shown hold smaller stakes.
The register reports 11 shareholders in total, though only the top 5 by holding are shown in this view.
Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 16.1% | Washington Secretary of State | |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 4.1% | Washington Secretary of State | |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 2.6% | Washington Secretary of State | |
| iShares Trust-iShares Russell 2000 ETF | 2% | Washington Secretary of State | |
| ALGER INSTITUTIONAL FUNDS-Alger Focus Equity Fund | 1.3% | Washington Secretary of State |
Officers
5
The Governingperson of CIDARA THERAPEUTICS, INC. currently on record is Dan Burgess; five officers are currently on record for CIDARA THERAPEUTICS, INC., filed with Washington Secretary of State.
The register reports 10 officers in total, including past appointments, though only the 5 most relevant records are shown here.
Management authority at CIDARA THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.
Group Structure
CIDARA THERAPEUTICS, INC. sits 2 levels below its ultimate parent, Merck & Co., Inc., registered in United States. 2 subsidiaries are recorded beneath it, across 3 jurisdictions. The full chain up to Merck & Co., Inc. is derived by walking shareholder filings across jurisdictions; no link in it is independently corroborated by CIDARA THERAPEUTICS, INC.'s own shareholder record. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.
Those 2 subsidiaries span United States, United Kingdom, Ireland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Merck & Co., Inc.
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
Who owns CIDARA THERAPEUTICS, INC.?
Five shareholders are currently on record for CIDARA THERAPEUTICS, INC., reflecting the stock ledger maintained under state corporate law (e.g. §219 of the Delaware General Corporation Law) rather than a public filing. The largest of these is Bain Capital Life Sciences Investors, LLC, holding 16.1% — the largest recorded stake — followed by VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund at 4.1%; the remaining 3 shareholders shown hold smaller stakes. Because every shareholder shown is a company rather than an individual, the ownership chain continues above this level, and no beneficial owner can be established from this filing alone.
Who is CIDARA THERAPEUTICS, INC.'s UBO (Ultimate Beneficial Owner)?
Every shareholder recorded for CIDARA THERAPEUTICS, INC. is itself a company rather than a natural person, so no Ultimate Beneficial Owner (UBO) is identified at this level; establishing one would require tracing the ownership of each shareholding company in turn.
How many shareholders does CIDARA THERAPEUTICS, INC. have on record?
5 shareholders are shown on record for CIDARA THERAPEUTICS, INC.. The register reports 11 in total; only the top 5 by holding are shown here.
What is CIDARA THERAPEUTICS, INC.'s company registration number?
CIDARA THERAPEUTICS, INC.'s registration number is 604624397, filed with Washington Secretary of State in United States. Its current status on the register is active.
Is CIDARA THERAPEUTICS, INC. still an active company?
CIDARA THERAPEUTICS, INC.'s status on Washington Secretary of State is listed as active.
When was CIDARA THERAPEUTICS, INC. incorporated?
CIDARA THERAPEUTICS, INC. was incorporated on 6 July 2020, according to Washington Secretary of State.
What is CIDARA THERAPEUTICS, INC.'s registered address?
The registered address on file for CIDARA THERAPEUTICS, INC. is SAN DIEGO, United States.
Who are the officers/directors of CIDARA THERAPEUTICS, INC.?
The Governingperson of CIDARA THERAPEUTICS, INC. currently on record is Dan Burgess; five officers are currently on record for CIDARA THERAPEUTICS, INC., filed with Washington Secretary of State. Management authority at CIDARA THERAPEUTICS, INC. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.
Does CIDARA THERAPEUTICS, INC. have a parent company or subsidiaries?
CIDARA THERAPEUTICS, INC. sits 2 levels below its ultimate parent, Merck & Co., Inc., registered in United States. 2 subsidiaries are recorded beneath it, across 3 jurisdictions. Those 2 subsidiaries span United States, United Kingdom, Ireland jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.
Can Zavia monitor changes to CIDARA THERAPEUTICS, INC.'s ownership over time?
This profile reflects a point-in-time snapshot from Washington Secretary of State. Zavia's monitoring API can track changes to CIDARA THERAPEUTICS, INC.'s registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access CIDARA THERAPEUTICS, INC.'s data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like CIDARA THERAPEUTICS, INC.'s registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from Washington Secretary of State and was last synced on 6 October 2026.